Peter Rudd-Clarke, a Partner in Osborne Clarke’s life sciences and healthcare team, Tamara Quinn, a Director in Osborne Clarke’s AI, data and IP knowledge team, and Julia Smith, an associate in Osborne Clarke’s commercial team, provide a detailed breakdown of the approach being taken to artificial intelligence within the life sciences sector and the upcoming regulatory developments
.png&w=3840&q=75)
